Acucela Inc. Announces Ryo Kubota, M.D., Ph.D., Named to PharmaVOICE 100

SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, today announced that Ryo Kubota, M.D., Ph.D., founder, chairman, president and chief executive officer of Acucela, has been featured in the 2011 PharmaVOICE 100, a listing of the 100 Most Inspiring People in the Life Sciences Industry.
MORE ON THIS TOPIC